Measuring disturbance of the endocannabinoid system in psychosis: A systematic review and meta-analysis
<p><strong>Importance</strong> The endocannabinoid system (ECS) is a lipid-based endogenous signaling system. Its relevance to psychosis is through the association between cannabis use and the onset and course of illness and through the antipsychotic properties of cannabidiol, a p...
Main Authors: | Minichino, A, Senior, M, Brondino, N, Zhang, S, Godlewska, B, Burnet, P, Cipriani, A, Lennox, B |
---|---|
Format: | Journal article |
Published: |
American Medical Association
2019
|
Similar Items
-
The gut-microbiome-endocannabinoid axis and anhedonia/amotivation: A mediation analysis in a general population cohort
by: A. Minichino, et al.
Published: (2021-04-01) -
The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies
by: Minichino, A, et al.
Published: (2020) -
The gut-microbiota as a target for the treatment of negative symptoms of schizophrenia: a systematic review and meta-analysis of controlled trials of add-on strategies
by: Minichino, A, et al.
Published: (2020) -
Specialised early intervention teams for first episode psychosis
by: Puntis, S, et al.
Published: (2019) -
Investigating the pro-cognitive and anti-depressant efficacy of metformin: a systematic review and meta-analysis of randomised controlled trials
by: Nibber, A, et al.
Published: (2022)